Literature DB >> 3266563

Cerebral circulation and oxygen metabolism in moyamoya disease of ischemic type in children.

W Taki1, Y Yonekawa, A Kobayashi, M Ishikawa, H Kikuchi, S Nishizawa, M Senda, Y Yonekawa, H Fukuyama, K Harada.   

Abstract

Cerebral rCBF, rOEF, rCMRO2, and rCBV in moyamoya disease were studied by means of positron emmission tomography (PET), using 15O as a tracer. Steady-state methods with C15O2 and 15O2 were used to obtain the functional images of rCBF, rCMRO2, and rOEF. The 15O single-inhalation method was used to obtain the rCBV image. Five children (two boys and three girls) with mean age of 11 years and eight normal volunteers with mean age of 31 years were included in the study. The symptoms of moyamoya disease were due to cerebral ischemia, such as transient ischemic attack (TIA), reversible ischemic neurological deficit (RIND), and minor stroke. The interval between the latest ictus and PET scan ranged from 3 days to 3 years 6 months. Physiological parameters (rCBF, rCMRO2 etc.) in cerebral gray matter, cerebral white matter and basal ganglia were calculated from the single functional images. Any, low density areas appearing in X-ray-CT performed just prior to the PET study were carefully excluded from the analysis. The parameters of moyamoya disease were statistically compared with normal control parameters. Though the value of rCBF was slightly higher in moyamoya disease, this difference was not statistically significant. On the other hand, in moyamoya disease rCBV increased significantly in gray matter, white matter, and basal ganglia. The ratio of CBF to CBV is considered to be the index of perfusion pressure and reciprocal of cerebral mean transit time under the normal autoregulation of CBF. This ratio was calculated and compared with the normal value for each tissue.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266563     DOI: 10.1007/bf00271919

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  8 in total

1.  Human cerebral blood flow and oxygen consumption as related to aging.

Authors:  S S KETY
Journal:  J Chronic Dis       Date:  1956-05

2.  Regional cerebral blood flow in apoplexy without arterial occlusion.

Authors:  O B Paulson; N A Lassen; E Skinhoj
Journal:  Neurology       Date:  1970-02       Impact factor: 9.910

3.  Regional cerebral blood flow and its autoregulation in patients with transient focal cerebral ischemic attacks.

Authors:  E Skinhoj; K Hoedt-Rasmussen; O B Paulson; N A Lassen
Journal:  Neurology       Date:  1970-05       Impact factor: 9.910

4.  Performance characteristics of Positologica III: a whole-body positron emission tomograph.

Authors:  M Senda; N Tamaki; Y Yonekura; S Tanada; K Murata; N Hayashi; T Fujita; H Saji; J Konishi; K Torizuka
Journal:  J Comput Assist Tomogr       Date:  1985 Sep-Oct       Impact factor: 1.826

5.  [Cerebral hemodynamics in patients with moyamoya disease (Part I). Evaluation of epicerebral microcirculation by fluorescein angiography].

Authors:  S Takeuchi
Journal:  Neurol Med Chir (Tokyo)       Date:  1983-09       Impact factor: 1.742

6.  A statistical study of the steady state technique for measuring regional cerebral blood flow and oxygen utilisation using 15O.

Authors:  A A Lammertsma; J D Heather; T Jones; R S Frackowiak; G L Lenzi
Journal:  J Comput Assist Tomogr       Date:  1982-06       Impact factor: 1.826

7.  Reduction in regional cerebral blood flow during normal aging in man.

Authors:  E Melamed; S Lavy; S Bentin; G Cooper; Y Rinot
Journal:  Stroke       Date:  1980 Jan-Feb       Impact factor: 7.914

8.  [Regional cerebral blood flow in children--normal value and regional distribution of cerebral blood flow in childhood].

Authors:  A Ogawa; N Nakamura; K Sugita; Y Sakurai; T Kayama; T Wada; J Suzuki
Journal:  No To Shinkei       Date:  1987-02
  8 in total
  1 in total

Review 1.  Quantitative hemodynamic studies in moyamoya disease: a review.

Authors:  Marco Lee; Greg Zaharchuk; Raphael Guzman; Achal Achrol; Teresa Bell-Stephens; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.